The human major histocompatibility complex (MHC) class I chain-related gene A (MICA), located 46 kb centromeric to HLA-B, encodes a stress-inducible protein, which is a ligand for the NKG2D receptor. In addition to its primary role in immune surveillance, data suggest that MICA is involved in the immune response to transplants and in susceptibility to some diseases. In this study, 152 subjects from the Yoruba (n¼74), Efik (n¼32), and Igbo (n¼46) tribes of southern Nigeria, 39 nationwide African-American stem cell donors, and 60 African-American individuals residing in the metropolitan Boston area were studied for MICA, HLA-B allelic variation, haplotypic diversity, and linkage disequilibrium (LD). MICA and HLA-B exhibited a high degree of genetic diversity among the populations studied. In particular, MICA allele and HLA-B-MICA haplotype frequencies and LD in the Efik and Igbo tribes were significantly different from the other study groups. HLA-B and MICA loci demonstrated significant global LD in all five populations (P-values o0.00001). LD also varied in a haplotype-specific manner. A novel MICA allele was detected in the Boston population. These findings are important from an anthropologic perspective, and will inform future HLA-linked disease association studies in related ethnic groups of African-derived ancestry.
Introduction
The human major histocompatibility complex (MHC) encompasses a 4 Mb genomic segment on chromosome 6p21. 3 . From telomere to centromere, the MHC is divided into class I, III, and II regions. On the 2 Mb class I segment, multiple MHC class I chain-related (MIC) loci have been identified. [1] [2] [3] The genes at these loci represent a second lineage of mammalian MHC class I genes. MICA (MHC class I chain-related gene A; MIM 600169) maps about 46 kb centromeric to the HLA-B locus and encodes a cell-surface glycoprotein that is expressed in keratinocytes and gastrointestinal epithelium, 1, 4 and in several other cell types. 5 MICA functions as one of the ligands for NKG2D/DAP10, 6 an activating immunoreceptor complex expressed on natural killer (NK) cells, gd T cells, and CD8
þ ab T cells. 7 MICA triggers the cytolysis mediated by NKG2D-bearing cells 7 and also costimulates CD8 þ ab T cells in pathogen-specific immune response. 8 MICA displays a high degree of allelic polymorphism within the nonclassical HLA gene loci. 9 Some of these polymorphisms modulate binding affinities with NKG2D. 10 Recent studies 11, 12 suggest that MICA might be an additional histocompatibility locus.
Sub-Saharan African populations studied to date exhibit a high degree of HLA gene diversity. 13, 14 Although several HLA gene frequency studies and two MICA reports include data on African-American subjects, [15] [16] [17] [18] [19] [20] there is little information available regarding their ancestral population groups. Presently, the information on MICA allelic frequencies in sub-Saharan Africans is limited to a single cell line of South African origin (9021-RSH) in the International Histocompatibility Workshop collection. 21 In the current study, we investigated MICA and HLA-B allelic variation and haplotypic diversity in three Nigerian tribal populations and two African-American populations.
Results

MICA and HLA-B allelic distributions
In accordance with our previous report, 19 MICA allele assignment was based on the integrated information of exons 2-5. A total of 9-15 MICA alleles were observed in the five study groups. MICA*00201, *004, and *00801 were commonly observed in all groups, with combined gene frequencies ranging from 71.6 to 80.4% (Table 1) . Pairwise comparisons of MICA allele frequencies revealed significant overall differences between the three Nigerian tribes. MICA allele frequencies in the Efik and Igbo tribes were also significantly different from each of the African-American populations (data not shown).
In all, 21-33 HLA-B alleles were observed in the five populations, indicating a more heterogeneous allelic distribution at the HLA-B locus (Table 1) . HLA-B*5301 was the most common allele in all populations except the Efik tribe, in which HLA-B*1503 predominated. Overall HLA-B allele frequencies in the Efik tribe were significantly different from each of the other populations. In addition, HLA-B allele frequencies in the Yoruba and Igbo tribes were significantly different from the nationwide African-American study population (data not shown).
MICA and HLA-B Hardy-Weinberg equilibrium and Ewens-Watterson homozygosity tests
The MICA and HLA-B allelic distributions in each study population were consistent with Hardy-Weinberg proportions, with the exception of HLA-B in the Igbo tribe (P¼0.01). Observed values of the Ewens-Watterson homozygosity statistic at the MICA locus were consistent with neutral expectations for all populations. The observed Ewens-Watterson homozygosity statistics at the HLA-B locus in the Efik and Igbo tribes were significantly higher than neutrality expectations (P¼0.04 and 0.03, respectively), whereas the Yoruba tribe showed a marginal value (P¼0.06).
Accuracy of imputed HLA-B-MICA haplotypes To assess the reliability of the deduced HLA-B-MICA haplotypes reported here, 33 African-American families were typed for HLA-B, MICA at high resolution in this study. A total of 57 parental samples were determined for HLA-B-MICA haplotype by a maximum likelihood method and by family segregation. All families were informative and produced unambiguous phase. Concordance between the haplotypes imputed using the maximum likelihood method and by family segregation was found in 107/114 (93.9%) haplotypes. Each of the remaining seven haplotypes involved a distinct HLA-B allele and had a frequency less than 5% in the study populations (data not shown).
HLA-B-MICA haplotype frequencies and linkage disequilibrium In all, 12 haplotypes had a frequency Z5% in at least one population ( Table 2 ) and were chosen for linkage disequilibrium (LD) analysis. HLA-B*5301-MICA*00201 was the most common haplotype in the Boston AfricanAmerican, Yoruba, and Igbo groups. In the nationwide African-American and Efik populations, HLA-B*4201-MICA*004 and HLA-B*1503-MICA*00801 predominated, respectively. Pairwise comparisons revealed that overall HLA-B-MICA haplotype frequencies in the Efik and Igbo tribes were significantly different from each other and from both African-American groups (data not Trinucleotide repeat polymorphism of 22 types of MICA allele A total of 22 MICA alleles were detected in our sample panels, including MICA*021,*030 for which the (GCT) repeat number in exon 5 has not been previously reported (http://www.anthonynolan.com/HIG/seq/ nuc/text/mica_nt.txt). The trinucleotide repeat showed a much restricted size polymorphism, in contrast to the high sequence diversification in exons 2-4 in the study populations (Table 3) .
Discussion
This study was designed to investigate genetic diversity in HLA-B and MICA in population groups where no previous MICA data existed. These data have demonstrated a high degree of genetic heterogeneity among sub-Saharan African-derived populations at these loci.
The HLA complex contains three clusters of genes that are essential to immune response. Class I genes (HLA-A, -B, and -C w ) present endogenously derived peptides to CD8 þ ab T cells. Their allelic repertoires have been maintained to present an infinite number of antigenic epitopes. 22 Molecular typing of HLA-B class I or MHC class I associated antigens (MICA) in Nigerian population groups has not been reported previously although earlier studies performed by serology are known. 23, 24 We have therefore evaluated the HLA-B data in the present report relative to these previous findings. It was clear from previous studies 23, 34 that detection of HLA specificities in Nigerians was dependent on regional representation of the various linguistic and culturally different groups. In this respect, our present report on HLA-B locus antigens confirms our previous serological report 23 in several ways, in that two major ethnic groups from southern Nigeria included in that report were also well represented in this work. We have also detected HLA-B antigenic specificities reported for the first time by our 'regional approach' study in Nigerians but missed previously. In particular, HLA-B8 and -B14 were not detected by Okoye et al 24 , whereas HLA-B13 was not reported in previous samples of West Africans. 25 By inclusion of the Efik group in the present study, we have detected a sub-Saharan African population that appears to be genetically distinct from other Nigerian tribal groups studied to date. This is best exemplified by 26 possibly admixed with neighboring tribal groups in Cameroon. 27 Our present study identified two haplotypes involving the same HLA-B allele, namely HLA-B*5301-MICA*00201 and HLA-B*5301-MICA*041. HLA-B*5301-MICA*00201 is a common haplotype among African-Americans but, among the Nigerians, it was in significant LD only in the Yoruba tribe. In contrast, the HLA-B*5301-MICA*041 haplotype was in LD exclusively in the Igbo and Efik tribes. This finding is of particular importance to the field of transplantation medicine, as data continue to emerge about the role of MICA in transplant rejection. Subjects with HLA-B*5301 may require MICA allelic assignment to ensure optimal selection of allogeneic donors. Although we hypothesize that the HLA-B*5301-MICA*00201 haplotype seen in African-Americans is derived from their putative enslaved Yoruba ancestors, we cannot exclude the possible contribution of recent admixture with Caucasian populations to the high frequency of this haplotype.
HLA-B*15 encoding alleles displayed complex MICA allelic association patterns in this study. HLA-B*1503 was in LD with MICA*00801 in all populations. HLA-B*1503 was also found to segregate with MICA*019 and MICA*CHAH. HLA-B*1510 was in LD with MICA*00802 except in the Igbo tribe, whereas HLA-B*1516 did not demonstrate LD with MICA alleles in any of the five groups. MICA diversity on HLA-B*15 haplotypes could have implications for risk of graft-vs-host disease (GVHD) in African-American allogeneic stem cell transplant recipients.
Our data demonstrate clear ethnic distinctions of the MICA allelic repertoire among sub-Saharan Africanderived populations. The similar findings in aggregate Caucasian samples 20 and ethnic groups in Asian populations 28 are consistent with a high degree of genomic diversity in the MICA gene.
HLA-B and MICA loci demonstrated significant global LD in all five populations (P-values o0.00001). This finding is consistent with previous hypotheses that there has been very little recombination between the HLA-B and MICA loci during the successive duplications that engender the present HLA class I region. 29, 30 It is worth noting that LD also varied within this genomic region in a haplotype-specific manner. Strong LD was found across populations in HLA-B*1503-MICA*00801 haplotype while confined to certain populations in several haplotypes. Knowledge of haplotype-specific LD may provide valuable information with regard to modern populations' ancestry, admixture, and the selective pressures maintaining such an LD.
Pairwise comparisons revealed that overall HLA-B-MICA haplotype frequencies differed between each African-American group and the Efik and Igbo tribes but not between the Yoruba tribe and the Boston-area African-Americans. This observation may be explained by the fact that the Atlantic slave trade drew more heavily on the Yoruba, relative to the Efik and Igbo. 31 Nonsynonymous substitutions are far more prevalent than synonymous ones in the MICA gene, suggesting some sort of selection. In our study, MICA genotype distributions fit a neutrality model in all five populations. MICB and UL16-binding protein also function as NKG2D ligands. 32 The presence of multiple NKG2D ligands may reduce pathogen-driven selection on the MICA gene. In contrast, the excess of HLA-B homozygosity in the Nigerian tribal populations may have been shaped by directional selection to eliminate some endemic pathogens. The HLA-B allelic distribution in the Igbo tribe departed from Hardy-Weinberg equilibrium. This observation may reflect the effects of inbreeding, outbreeding, relatively small sample size, or even misgenotyping. From the data available, we cannot assess breeding patterns in the Igbo. Resources are not available to permit additional sample collection from Igbo tribal members. Misgenotyping seems unlikely when we consider the consistency of results between our previous family studies 19 and this current analysis. Thus, the findings in the Igbo may require confirmation in larger data sets in the future.
A novel MICA allele was observed in an AfricanAmerican family residing in Boston. It appears that this new allele is evolutionarily linked to MICA*019. This novel MICA variant was not found in any of the other populations involved in the present study, possibly suggesting a yet unknown ethnic origin.
In conclusion, our data demonstrate a high degree of MICA gene diversity in sub-Saharan African-derived populations. These data will provide a basis for future studies of the potential role of MICA in allogeneic stem cell and solid organ transplantation as well as infectious and autoimmune disease susceptibility in these populations. MICA is an important candidate gene for a number of clinically significant diseases including diabetes, 33 rheumatoid arthritis, 34, 35 and other autoimmune diseases. [36] [37] [38] [39] It is increasingly clear that knowledge of population-specific allelic and haplotypic structure is critical for genotype-phenotype association studies. 40 Our study will therefore inform such future studies in African-American and sub-Saharan African populations.
Materials and methods
Subjects
The study included five distinct study populations. The first group comprised 60 unrelated healthy AfricanAmerican individuals residing in the metropolitan Boston area, Massachusetts. The second group was composed of 39 African-American stem cell donors provided by the US National Marrow Donor Program (NMDP). Of the 60 donor-recipient pairs provided to us in whom all recipients were African-American, 21 of the donors were not African-American, and therefore were excluded from the analysis. The last three groups comprised 152 subjects recruited from three culturally and linguistically distinct tribes residing in southern Nigeria-Yoruba (n¼74), Efik (n¼32), and Igbo (n¼46). The Nigerian subjects were random volunteers from different locations within southern Nigeria.
Each study population consisted of healthy and unrelated adults of self-reported ethnicity. Among the Boston subjects, 46.7% (28/60) were male and 53.3% (32/60) were female. Approximately two-thirds of the Nigerian study subjects were male and the remaining one-third was female. In the Yoruba tribe, 66.2% (49/74) were male and 33.8% (25/74) were female. In the Efik tribe, 62.5% (20/32) were male and 37.5% (12/32) All subjects voluntarily provided 10 ml of EDTA blood samples from which DNA was extracted using Qiagen kits (Valencia, CA, USA) according to the manufacturer's specification. There were no missing genotypic data. All protocols were approved by the Institutional Review Boards of local hospitals.
Reference DNAs
Genomic DNA from previously used heterozygous and homozygous cell lines 19, 20 were included in MICA genotyping. 
HLA-B high-resolution typing
A two-step strategy, 19 low-or intermediate-resolution typing by PCR-SSOP followed by allelic typing by PCR-SSP, was used for HLA-B allelic typing for all samples except for the 60 African-American donors, for which NMDP provided the HLA-B data. Confirmatory typing was carried out for selected samples that deviated from expected HLA-B-MICA associations.
19
MICA high-resolution typing Exons 2-4 of the MICA gene were amplified separately as previously described. 19 A panel of 64 allele-or groupspecific probes was used to detect all known polymorphic sites at exons 2-4 of the MICA gene and to distinguish ambiguous allelic combinations encountered in our study. The (GCT) n microsatellite at exon 5 was analyzed as described 41 with previously reported modifications. 19 Cycle sequencing Low-frequency MICA alleles (MICA*017, *021, *030, *041, *045, and *046) were confirmed by cycle sequencing 19 following PCR-SSOP.
Identification of a novel MICA allele
A new PCR-SSOP hybridization pattern, differing from that of MICA*019 in exon 4 by a single probe reaction, was observed in two members of an African-American family previously studied, 19 one of whom is included in the present study. PCR products of exon 4 derived from both samples were therefore cloned using a TOPO s TA cloning kit according to the manufacturer's protocol (Invitrogen, Carlsbad, CA, USA). Multiple inserts were sequenced in both directions following the protocol previously described. 19 
Statistical analysis
The programs Arlequin, 42 CLUMP, 43 MONTE-CAR-LO 44, 45 and GDA 46 were used to analyze the data. Pvalues were derived by empirical simulation where possible, and statistical significance was defined at the 5% level. Comparisons of allele and haplotype frequencies among populations and LD analyses were restricted to alleles and haplotypes, with a frequency Z5% in at least one study population. Exact, permutation-based tests 43 were used for all contingency table inference. Consistency of genotype frequencies at each locus with Hardy-Weinberg equilibrium was tested on a contingency table of observed vs predicted genotype frequencies using a modified Markov-chain random walk algorithm. 47 The Ewens-Watterson's homozygosity statistic 48, 49 was calculated with the MONTE CARLO program. 44, 45 LD was calculated using an iterative maximum-likelihood method 50 and expressed as either D or D 0 . 51 The statistical significance of LD between MICA and HLA-B was tested using a likelihood-ratio test, whose empirical distribution was obtained by a permutation procedure 52 as implemented in Arlequin. 42 Maximum likelihood haplotype frequencies were imputed within each group of subjects using an expectation-maximization (EM) approach, 53 as implemented in the program Arlequin. The EM algorithm was repeated from 20 different starting points. Standard deviations were estimated using a parametric bootstrap procedure.
